7-Hydroxy-DPAT (hydrobromide)

• Description:

  7-Hydroxy-DPAT hydrobromide is a selective D3 dopamine receptor agonist, exhibiting significant pharmacological activity in modulating locomotor behavior and dopamine metabolism within the brain.

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Dopamine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/7-hydroxy-dpat-hydrobromide.html

• Purity:

  99.84

• Solubility:

  DMSO : 50 mg/mL (ultrasonic)

• Smiles:

  OC1=CC=C2CCC(N(CCC)CCC)CC2=C1.Br

• Molecular Formula:

  C16H26BrNO

• Molecular Weight:

  328.29

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Acute haloperidol attenuates the hypomotility induced with 7-hydroxy-DPAT

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [76135-30-3]